The Tryton Side Branch Stent™ for the treatment of coronary bifurcation lesions

References

• Sarno G, Lagerqvist B, Frobert O et al. Lower risk of stent thrombosis and restenosis with unrestricted use of ‘new-generation’ drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur. Heart J.33(5), 606–613 (2012).
   PubMed Web of Science ®Google Scholar
• Rathore S, Terashima M, Katoh O et al. Predictors of angiographic restenosis after drug eluting stents in the coronary arteries: contemporary practice in real world patients. EuroIntervention 5(3), 349–354 (2009).
   PubMedGoogle Scholar
• van Werkum JW, Heestermans AA, Zomer AC et al. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J. Am. Coll. Cardiol. 53(16), 1399–1409 (2009).
   PubMed Web of Science ®Google Scholar
• Hildick-Smith D, Lassen JF, Albiero R et al. Consensus from the 5th European Bifurcation Club meeting. EuroIntervention 6(1), 34–38 (2010).
   PubMedGoogle Scholar
• Pan M, de Lezo JS, Medina A et al. Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: a randomized comparison of a simple versus complex strategy. Am. Heart J.148(5), 857–864 (2004).
   PubMedGoogle Scholar
• Colombo A, Moses JW, Morice MC et al. Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions. Circulation 109(10), 1244–1249 (2004).
   PubMed Web of Science ®Google Scholar
• Ferenc M, Gick M, Kienzle RP et al. Randomized trial on routine vs. provisional T-stenting in the treatment of de novo coronary bifurcation lesions. Eur. Heart J. 29(23), 2859–2867 (2008).
   PubMed Web of Science ®Google Scholar
• Steigen TK, Maeng M, Wiseth R et al. Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study. Circulation 114(18), 1955–1961 (2006).
   PubMed Web of Science ®Google Scholar
• Colombo A, Bramucci E, Sacca S et al. Randomized study of the crush technique versus provisional side-branch stenting in true coronary bifurcations: the CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting S tents) Study. Circulation 119(1), 71–78 (2009).
   PubMedGoogle Scholar
• Hildick-Smith D, de Belder AJ, Cooter N et al. Randomized trial of simple versus complex drug-eluting stenting for bifurcation lesions: the British Bifurcation Coronary Study: old, new, and evolving strategies. Circulation 121(10), 1235–1243 (2010).
   PubMed Web of Science ®Google Scholar
• Garcia Del Blanco B, Marti G, Bellera N et al. Clinical and procedural evaluation of the Nile Croco(R) dedicated stent for bifurcations: a single centre experience with the first 151 consecutive non-selected patients. EuroIntervention 7(2), 216–224 (2011).
   PubMedGoogle Scholar
• Costa RA, Abizaid A, Abizaid AS et al. Procedural and early clinical outcomes of patients with de novo coronary bifurcation lesions treated with the novel Nile PAX dedicated bifurcation polymer-free paclitaxel coated stents: results from the prospective, multicentre, non-randomised BIPAX clinical trial. EuroIntervention 7(11), 1301–1309 (2012).
   PubMedGoogle Scholar
• Verheye S, Ramcharitar S, Grube E et al. Six-month clinical and angiographic results of the STENTYS(R) self-apposing stent in bifurcation lesions. EuroIntervention 7(5), 580–587 (2011).
   PubMed Web of Science ®Google Scholar
• Lefevre T, Ormiston J, Guagliumi G et al. The Frontier stent registry: safety and feasibility of a novel dedicated stent for the treatment of bifurcation coronary artery lesions. J. Am. Coll. Cardiol. 46(4), 592–598 (2005).
   PubMedGoogle Scholar
• Ormiston J, Webster M, El-Jack S, McNab D, Plaumann SS. The AST petal dedicated bifurcation stent: first-in-human experience. Catheter Cardiovasc. Interv. 70(3), 335–340 (2007).
   PubMedGoogle Scholar
• Kaplan AV, Davis HR. Tryton side-branch stent. EuroIntervention 2(2), 270–271 (2006).
   PubMedGoogle Scholar
• Magro M, van Geuns RJ. TheTryton side branch stent. EuroIntervention 6( Suppl. J), J147–J150 (2010).
   Google Scholar
• Grundeken MJ, Asgedom S, Damman P et al. Six-month and one-year clinical outcomes after placement of a dedicated coronary bifurcation stent: a patient-level pooled analysis of eight registry studies. EuroIntervention 9(2), 195–203 (2013).
   PubMed Web of Science ®Google Scholar
• Kaplan AV, Ramcharitar S, Louvard Y et al. Tryton I, First-In-Man (FIM) Study: acute and 30 day outcome.a preliminary report. EuroIntervention 3(1), 54–59 (2007).
   PubMedGoogle Scholar
• Onuma Y, Muller R, Ramcharitar S et al. Tryton I, First-In-Man (FIM) study: six month clinical and angiographic outcome, analysis with new quantitative coronary angiography dedicated for bifurcation lesions. EuroIntervention 3(5), 546–552 (2008).
   PubMedGoogle Scholar
• Medina A, Suarez de LJ, Pan M. A new classification of coronary bifurcation lesions. Rev. Esp. Cardiol. 59(2), 183 (2006).
   PubMed Web of Science ®Google Scholar
• Magro M, Wykrzykowska J, Serruys PW et al. Six-month clinical follow-up of the Tryton side branch stent for the treatment of bifurcation lesions: a two center registry analysis. Catheter Cardiovasc. Interv. 77(6), 798–806 (2011).
   PubMedGoogle Scholar
• Grundeken MJ, Smits M, Harskamp RE et al. Six-month clinical outcomes of the Tryton Side Branch Stent for the treatment of bifurcation lesions. Neth. Heart J. 20(11), 439–446 (2012).
   PubMedGoogle Scholar
• Beijk MA, Rittersma SZ, Koch KT et al. Percutaneous treatment of bifurcated lesions: a simple approach with a single bare metal R stent provides favourable long term clinical results. EuroIntervention 1(4), 409–416 (2006).
   PubMedGoogle Scholar
• Beijk MA, Klomp M, Koch KT et al. One-year clinical outcome after provisional T-stenting for bifurcation lesions with the endothelial progenitor cell capturing stent compared with the bare-metal stent. Atherosclerosis 213(2), 525–531 (2010).
   PubMedGoogle Scholar
• Grundeken MJ, Stella PR, Bethencourt A et al. Additional side branch stent placement in patients with long side branch lesions treated with the Tryton dedicated bifurcation side branch stent. Int. J. Cardiol. (doi:pii: S0167-5273(13) 00682-7) (2013) ( Epub ahead of print).
   Google Scholar
• Magro M, Girasis C, Bartorelli AL et al. Acute procedural and six-month clinical outcome in patients treated with a dedicated bifurcation stent for left main stem disease: the TRYTON LM multicentre registry. EuroIntervention 8(11), 1259–1269 (2013).
   PubMedGoogle Scholar
• Grundeken MJ, Agostoni P, Lesiak M et al. Placement of Tryton side branch stent only; a new treatment strategy for medina 0,0,1 coronary bifurcation lesions. Catheter Cardiovasc. Interv 82(4), E395–E402 (2013).
   Google Scholar
• Unzue L, Garcia E, Almeria C. Double bifurcation lesion treated with double tryton sidebranch stent: first case report. Catheter Cardiovasc. Interv. ( doi:10.1002/ccd.24858) (2013) ( Epub ahead of print).
   Google Scholar
• Grundeken MJ, Boerlage-van Dijk K, Wykrzykowska JJ. Treatment of in-stent restenosis involving a bifurcation lesion with a dedicated bifurcation device in combination with drug-eluting balloons. J. Invasive Cardiol. 24(8), E172–E175 (2012).
   Google Scholar
• Ferrante G, Kaplan AV, Di Mario C. Assessment with optical coherence tomography of a new strategy for bifurcational lesion treatment: the Tryton Side-Branch Stent. Catheter Cardiovasc. Interv. 73(1), 69–72 (2009).
   PubMedGoogle Scholar
• Tyczynski P, Ferrante G, Kukreja N et al. Optical coherence tomography assessment of a new dedicated bifurcation stent. EuroIntervention 5(5), 544–551 (2009).
   PubMed Web of Science ®Google Scholar
• Dubois C, Adriaenssens T, Ughi G et al. Healing responses after bifurcation stenting with the dedicated TRYTON side-branch Stent(TM) in combination with XIENCE-V(TM) stents: a clinical, angiography, fractional flow reserve and optical coherence tomography study. Catheter Cardiovasc. Interv. 81(3), E155–E164 (2012).
   Google Scholar
• Kelbaek H, Thuesen L, Helqvist S et al. The stenting coronary arteries in non-stress/benestent disease (SCANDSTENT) trial. J. Am. Coll. Cardiol. 47(2), 449–455 (2006).
   PubMedGoogle Scholar
• Morice MC, Serruys PW, Sousa JE et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N. Engl. J. Med. 346(23), 1773–1780 (2002).
   PubMed Web of Science ®Google Scholar
• Grube E, Wijns W, Schofer J, Steckel M, Leon M. FIM Results of the Capella Sideguard for Treatment of Coronary Bifurcations. Presented at: Transcatheter Cardiovascular Therapeutics (TCT) 2007.
   Google Scholar
• Doi H, Maehara A, Mintz GS, Dani L, Leon MB, Grube E. Serial intravascular ultrasound analysis of bifurcation lesions treated using the novel self-expanding sideguard side branch stent. Am. J. Cardiol. 104(9), 1216–1221 (2009).
   PubMedGoogle Scholar
• Mamas MA, Farooq V, Latib A et al. Use of the sideguard (cappella) stent in bifurcation lesions: a real-world experience. EuroIntervention 7(10), 1170–1180 (2012).
   PubMedGoogle Scholar
• Zimarino M, Corazzini A, Ricci F, Di Nicola M, De Catherina R. Late thrombosis after double versus single drug-eluting stent in the treatment of coronary bifurcations: a Meta-Analysis of randomized and observational studies. JACC Cardiovasc. Interv. 6(7), 687–695 (2013).
   PubMed Web of Science ®Google Scholar
• Nakazawa G, Yazdani SK, Finn AV, Vorpahl M, Kolodgie FD, Virmani R. Pathological findings at bifurcation lesions: the impact of flow distribution on atherosclerosis and arterial healing after stent implantation. J. Am. Coll. Cardiol 55(16), 1679–1687 (2010).
   PubMed Web of Science ®Google Scholar